PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, Weill Cornell Medical College, New York, New York, and Weill Cornell Medical College and Hamad Medical Corporation, Doha, Qatar (A.A.B.).\', \'Yale School of Medicine, New Haven, Connecticut (S.B.O.).\', \'VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania (P.Y.).\', \'VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (O.S.S.).\', \'VA Pittsburgh Healthcare System, University of Pittsburgh School of Medicine, and University of Pittsburgh, Pittsburgh, Pennsylvania (F.B.M.).\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.7326/M21-1577
?:doi
?:hasPublicationType
?:journal
  • Annals of internal medicine
is ?:pmid of
?:pmid
?:pmid
  • 34280332
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.466
?:rankingScore_hIndex
  • 349
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all